Hopes of ending the global HIV epidemic anytime soon are fading among health workers and scientists, who say new infections could increase for the first time in decades.

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...

The FDA approved Lenacapavir, the first twice-a-year injection to prevent HIV, marking a historic step in public health.

Tens of thousands of deaths and new HIV infections will be the direct result of Donald Trump’s abandonment of PEPFAR and ...

Tens of millions of people worldwide live with HIV. Lenacapavir can prevent the virus for months with one injection — a ...

New York State Assemblymember Zohran Mamdani, 33, shocked political observers with his likely upset of former Gov. Andrew ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...